Thanks a lot! - As you may have noticed from my bio, I would not be an objective observer about this.

It doesn't take long for certain people to change things, and mostly for the worse. And if a commentary co-written by a Stanford School of Business professor in yesterday's Wall Street Journal is any guide, things can get worse yet.

Congressional Democrats need to be careful in making the logical leap from market share to bargaining power. Empowering the government to negotiate with pharmaceutical companies is not necessarily equivalent to achieving lower drug prices. In fact, neither economic theory nor historical experience suggests that will be the outcome. Members should think carefully before jumping on the bandwagon - this promise may bring just the opposite of what was ordered.

Couldn't have said it any better myself!